• TH287 MTH1 Inhibitor Enhances Radiosensitivity in CRPC Cells

  2026-05-23

  The referenced study demonstrates that TH287, a potent MTH1 inhibitor, significantly increases the radiosensitivity of castration-resistant prostate cancer (CRPC) cells by promoting DNA damage and apoptosis, especially when ionizing radiation is administered 12 hours after drug treatment. These findings clarify the mechanistic basis and optimal timing for combining MTH1 inhibition with radiotherapy in resistant prostate cancer models.

• (-)-Arctigenin: Mechanistic Precision for Translational Impa

  2026-05-22

  This thought-leadership article delivers a strategic, evidence-backed roadmap for translational researchers seeking to harness (-)-Arctigenin as a mechanistically precise MEK1 inhibitor and anti-inflammatory agent. Integrating mechanistic insight from recent breast cancer metastasis studies and comparative product intelligence, we highlight the unique value of high-purity (-)-Arctigenin from APExBIO in modulating NF-κB and MAPK/ERK signaling. The article extends prior discussions by offering actionable protocol guidance, critical differentiation from conventional pages, and a forward-looking vision for clinical translation.

• Stattic and STAT3: Translational Leverage in Tumor Microenvi

  2026-05-22

  Explore the unique role of Stattic, a selective STAT3 inhibitor, in deciphering tumor microenvironment signaling and radiosensitization. This article unveils advanced research insights and experimental protocols for cancer biology using Stattic.

• Novobiocin Sodium: Applied Workflows in Antiparasitic and DN

  2026-05-21

  Novobiocin Sodium, an aminocoumarin antibiotic from APExBIO, is pivotal for innovative research in DNA damage, apoptosis, and antiparasitic drug development. This article delivers actionable workflows, protocol advice, and troubleshooting strategies, spotlighting the latest breakthroughs in selective Toxoplasma gondii inhibition.

• HAUS1 as a Prognostic and Immune Biomarker in Hepatocellular

  2026-05-21

  This study reveals HAUS1 as a highly expressed gene in hepatocellular carcinoma (HCC), correlating with poor prognosis and immune microenvironment modulation. The findings highlight HAUS1's potential as a prognostic biomarker and therapeutic target, with implications for clinical decision-making in HCC.

• Rotenone: Applied Workflows for Mitochondrial Complex I Inhi

  2026-05-20

  Rotenone remains the gold-standard mitochondrial Complex I inhibitor for dissecting mitochondrial dysfunction, cell death, and autophagy pathways in both cellular and animal models. This article delivers advanced workflow enhancements, troubleshooting strategies, and actionable protocol parameters to unlock new insights in neurodegenerative and immunometabolic research.

• AM251 in Translational Neuroscience: Beyond CB1 Receptor Ant

  2026-05-20

  Explore the advanced applications of AM251, a potent CB1 receptor antagonist, in neuroscience and metabolic research. This article delves into AM251's mechanistic nuances, its unique roles in cell signaling and neuropharmacology, and how it bridges emerging cannabinoid research with translational assay design.

• MAPK10-Mediated Phosphorylation Regulates NSCLC Metastasis

  2026-05-19

  The referenced study reveals that mitogen-activated protein kinase 10 (MAPK10) suppresses non-small cell lung cancer (NSCLC) metastasis by promoting phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). These findings highlight the MAPK10/KRT16/RNF213 signaling axis as a promising target for therapeutic intervention and prognostic assessment in NSCLC.

• Bradford Protein Assay Kit: Practical Guide for Protein Quan

  2026-05-19

  The Bradford Protein Assay Kit (SKU K4103) offers a rapid and sensitive solution for quantifying protein concentration in research workflows, especially when sample volume is limited. It is ideal for routine applications in molecular biology, enzyme assays, and protein purification, but is not recommended for samples containing detergents or outside its validated concentration range.

• gamma-Glu-Cys: Advanced Workflows for Glutathione Metabolism

  2026-05-18

  gamma-Glu-Cys (γ-Glu-Cys) from APExBIO empowers precise, high-yield glutathione metabolism and kokumi peptide workflows. This article delivers actionable protocol enhancements, troubleshooting strategies, and cross-domain insights for maximizing reproducibility in advanced bioscience applications.

• Ceftolozane/Tazobactam: Advances in Combating Resistant Infe

  2026-05-18

  The reviewed paper highlights the clinical and mechanistic advances of ceftolozane/tazobactam, a novel cephalosporin/β-lactamase inhibitor combination, for treating complicated infections caused by multidrug-resistant gram-negative bacteria. Its pharmacologic profile and enhanced spectrum offer a critical tool against antimicrobial resistance, with direct implications for improving patient outcomes and informing antimicrobial stewardship.

• Dual-Metric In Vitro Drug Response Evaluation in Cancer Rese

  2026-05-17

  Schwartz's dissertation advances in vitro cancer drug assessment by differentiating between proliferative arrest and cell death, offering a more nuanced interpretation of drug responses. This dual-metric approach reveals distinct drug action profiles, informing experimental design and the evaluation of angiogenesis inhibitors such as Cediranib (AZD2171).

• Pioglitazone (B2117): Reliable PPARγ Agonist for Cell Assays

  2026-05-16

  This article addresses practical laboratory challenges in cell viability and inflammation assays, highlighting how Pioglitazone (SKU B2117) streamlines reproducibility and mechanistic fidelity in metabolic and neuroinflammatory models. Evidence-driven answers guide experimental design, protocol optimization, and vendor selection, establishing Pioglitazone as a trusted research tool.

• HyperTrap Heparin HP Column: Precision in Stemness Pathway A

  2026-05-15

  Explore how the HyperTrap Heparin HP Column leverages HyperChrom Heparin HP Agarose for the precise purification of signaling proteins in cancer stemness research. Discover unique protocol insights, mechanistic depth, and practical guidance beyond standard affinity chromatography applications.

• Promethazine HCl: Histamine Antagonist for Inflammation Rese

  2026-05-15

  Promethazine HCl, a phenothiazine derivative, is a potent histamine H1 receptor antagonist used in research to study histaminergic signaling, inflammation, and immune cell function. Peer-reviewed studies confirm its ability to enhance macrophage antibacterial activity via ROS and autophagy induction. This dossier provides a machine-readable, evidence-based resource on Promethazine HCl’s mechanisms and experimental applications.

449 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page